Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Costa

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
BMC Gastroenterology|January 23, 2017
Diagnosis of celiac disease and applicability of ESPGHAN guidelines in Mediterranean countries: a real life prospective studyAndrea Smarrazzo, Zrinjka Misak, Stefano Costa, et al.
Inflammatory Bowel Diseases|February 27, 2014
Phenotype and disease course of early-onset pediatric inflammatory bowel diseaseMarina Aloi, Paolo Lionetti, Arrigo Barabino, et al.
Cell Reports|April 3, 2013
The SH2 domain interaction landscapeMichele Tinti, Lars Kiemer, Stefano Costa, et al.
Digestion|June 12, 2013
The importance of disease prevalence in assessing the diagnostic value of a test: endoscopic markers in celiac diseaseSalvatore Pellegrino, Federica Furfaro, Andrea Tortora, et al.
Frontiers in Pharmacology|December 3, 2024
Pharmacological rescue of the G85E CFTR variant by preclinical and approved modulatorsValeria Tomati, Valeria Capurro, Emanuela Pesce, et al.
The Journal of Pediatrics|August 28, 2024
Corrigendum to "Reported Adverse Events in a Multicenter Cohort of Patients Ages 6-18 years with Cystic Fibrosis and at Least one F508dek Allele Receiving Elexacaftor/Tezacaftor/Ivacaftor". J Pediatr. 2024 Jun 28; 274:114176Vito Terlizzi, Cristina Fevola, Santiago Presti, et al.
The Journal of Pediatrics|June 30, 2024
Reported Adverse Events in a Multicenter Cohort of Patients Ages 6-18 Years with Cystic Fibrosis and at Least One F508del Allele Receiving Elexacaftor/Tezacaftor/IvacaftorVito Terlizzi, Cristina Fevola, Santiago Presti, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|March 24, 2022
State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the "iMAging managEment of cySTic fibROsis" (MAESTRO) consortiumPierluigi Ciet, Silvia Bertolo, Mirco Ros, et al.
BMC Psychiatry|February 1, 2012
The characteristics and activities of child and adolescent mental health services in Italy: a regional surveyLaura Pedrini, Giovanni Colasurdo, Stefano Costa, et al.
Inflammatory Bowel Diseases|August 18, 2017
Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease CohortMatteo Bramuzzo, Gabriele Stocco, Marcella Montico, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
BMC Gastroenterology|January 23, 2017
Diagnosis of celiac disease and applicability of ESPGHAN guidelines in Mediterranean countries: a real life prospective studyAndrea Smarrazzo, Zrinjka Misak, Stefano Costa, et al.
Inflammatory Bowel Diseases|February 27, 2014
Phenotype and disease course of early-onset pediatric inflammatory bowel diseaseMarina Aloi, Paolo Lionetti, Arrigo Barabino, et al.
Cell Reports|April 3, 2013
The SH2 domain interaction landscapeMichele Tinti, Lars Kiemer, Stefano Costa, et al.
Digestion|June 12, 2013
The importance of disease prevalence in assessing the diagnostic value of a test: endoscopic markers in celiac diseaseSalvatore Pellegrino, Federica Furfaro, Andrea Tortora, et al.
Frontiers in Pharmacology|December 3, 2024
Pharmacological rescue of the G85E CFTR variant by preclinical and approved modulatorsValeria Tomati, Valeria Capurro, Emanuela Pesce, et al.
The Journal of Pediatrics|August 28, 2024
Corrigendum to "Reported Adverse Events in a Multicenter Cohort of Patients Ages 6-18 years with Cystic Fibrosis and at Least one F508dek Allele Receiving Elexacaftor/Tezacaftor/Ivacaftor". J Pediatr. 2024 Jun 28; 274:114176Vito Terlizzi, Cristina Fevola, Santiago Presti, et al.
The Journal of Pediatrics|June 30, 2024
Reported Adverse Events in a Multicenter Cohort of Patients Ages 6-18 Years with Cystic Fibrosis and at Least One F508del Allele Receiving Elexacaftor/Tezacaftor/IvacaftorVito Terlizzi, Cristina Fevola, Santiago Presti, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|March 24, 2022
State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the "iMAging managEment of cySTic fibROsis" (MAESTRO) consortiumPierluigi Ciet, Silvia Bertolo, Mirco Ros, et al.
BMC Psychiatry|February 1, 2012
The characteristics and activities of child and adolescent mental health services in Italy: a regional surveyLaura Pedrini, Giovanni Colasurdo, Stefano Costa, et al.
Inflammatory Bowel Diseases|August 18, 2017
Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease CohortMatteo Bramuzzo, Gabriele Stocco, Marcella Montico, et al.
Pageof 8